One of the hardest goals to accomplish within the biotechnology sector is to find a stock that has the potential to be huge within a few years. I believe that LPath (NASDAQ:LPTN) represents a significant opportunity for investors, and thus represents a compelling chance at significant upside for investors who are focused upon the long term. Currently, LPath has a promising pipeline that is progressing through the stages of clinical development, and this pipeline represents a compelling opportunity for investors. Add in the fact that LPath has a partnership with one of the largest pharmaceutical companies in the world for a rather important product, and the potential for this small cap stock does seem to be very large....
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|